Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Dec 1;102(11):1978–1985. doi: 10.1172/JCI4814

Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.

E R Levin 1, G F Rosen 1, D L Cassidenti 1, B Yee 1, D Meldrum 1, A Wisot 1, A Pedram 1
PMCID: PMC509150  PMID: 9835623

Abstract

Controlled ovarian hyperstimulation with gonadotropins is followed by Ovarian Hyperstimulation Syndrome (OHSS) in some women. An unidentified capillary permeability factor from the ovary has been implicated, and vascular endothelial cell growth/permeability factor (VEGF) is a candidate protein. Follicular fluids (FF) from 80 women who received hormonal induction for infertility were studied. FFs were grouped according to oocyte production, from group I (0-7 oocytes) through group IV (23-31 oocytes). Group IV was comprised of four women with the most severe symptoms of OHSS. Endothelial cell (EC) permeability induced by the individual FF was highly correlated to oocytes produced (r2 = 0.73, P < 0.001). Group IV FF stimulated a 63+/-4% greater permeability than FF from group I patients (P < 0. 01), reversed 98% by anti-VEGF antibody. Group IV fluids contained the VEGF165 isoform and significantly greater concentrations of VEGF as compared with group I (1,105+/-87 pg/ml vs. 353+/-28 pg/ml, P < 0. 05). Significant cytoskeletal rearrangement of F-actin into stress fibers and a destruction of ZO-1 tight junction protein alignment was caused by group IV FF, mediated in part by nitric oxide. These mechanisms, which lead to increased EC permeability, were reversed by the VEGF antibody. Our results indicate that VEGF is the FF factor responsible for increased vascular permeability, thereby contributing to the pathogenesis of OHSS.

Full Text

The Full Text of this article is available as a PDF (807.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramov Y., Barak V., Nisman B., Schenker J. G. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril. 1997 Feb;67(2):261–265. doi: 10.1016/S0015-0282(97)81908-5. [DOI] [PubMed] [Google Scholar]
  2. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994 Dec 1;331(22):1480–1487. doi: 10.1056/NEJM199412013312203. [DOI] [PubMed] [Google Scholar]
  3. Asch R. H., Li H. P., Balmaceda J. P., Weckstein L. N., Stone S. C. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod. 1991 Nov;6(10):1395–1399. doi: 10.1093/oxfordjournals.humrep.a137276. [DOI] [PubMed] [Google Scholar]
  4. Bacallao R., Garfinkel A., Monke S., Zampighi G., Mandel L. J. ATP depletion: a novel method to study junctional properties in epithelial tissues. I. Rearrangement of the actin cytoskeleton. J Cell Sci. 1994 Dec;107(Pt 12):3301–3313. doi: 10.1242/jcs.107.12.3301. [DOI] [PubMed] [Google Scholar]
  5. Bacallao R., Garfinkel A., Monke S., Zampighi G., Mandel L. J. ATP depletion: a novel method to study junctional properties in epithelial tissues. I. Rearrangement of the actin cytoskeleton. J Cell Sci. 1994 Dec;107(Pt 12):3301–3313. doi: 10.1242/jcs.107.12.3301. [DOI] [PubMed] [Google Scholar]
  6. Barry P. A., Petroll W. M., Andrews P. M., Cavanagh H. D., Jester J. V. The spatial organization of corneal endothelial cytoskeletal proteins and their relationship to the apical junctional complex. Invest Ophthalmol Vis Sci. 1995 May;36(6):1115–1124. [PubMed] [Google Scholar]
  7. Blum M. S., Toninelli E., Anderson J. M., Balda M. S., Zhou J., O'Donnell L., Pardi R., Bender J. R. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am J Physiol. 1997 Jul;273(1 Pt 2):H286–H294. doi: 10.1152/ajpheart.1997.273.1.H286. [DOI] [PubMed] [Google Scholar]
  8. Cavender J. L., Murdoch W. J. Morphological studies of the microcirculatory system of periovulatory ovine follicles. Biol Reprod. 1988 Nov;39(4):989–997. doi: 10.1095/biolreprod39.4.989. [DOI] [PubMed] [Google Scholar]
  9. Clancy R. M., Rediske J., Tang X., Nijher N., Frenkel S., Philips M., Abramson S. B. Outside-in signaling in the chondrocyte. Nitric oxide disrupts fibronectin-induced assembly of a subplasmalemmal actin/rho A/focal adhesion kinase signaling complex. J Clin Invest. 1997 Oct 1;100(7):1789–1796. doi: 10.1172/JCI119706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ferrara N., Winer J., Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors. 1991;5(2):141–148. doi: 10.3109/08977199109000278. [DOI] [PubMed] [Google Scholar]
  11. Furuse M., Itoh M., Hirase T., Nagafuchi A., Yonemura S., Tsukita S., Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol. 1994 Dec;127(6 Pt 1):1617–1626. doi: 10.1083/jcb.127.6.1617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garrido C., Saule S., Gospodarowicz D. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors. 1993;8(2):109–117. doi: 10.3109/08977199309046931. [DOI] [PubMed] [Google Scholar]
  13. Goldsman M. P., Pedram A., Dominguez C. E., Ciuffardi I., Levin E., Asch R. H. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril. 1995 Feb;63(2):268–272. doi: 10.1016/s0015-0282(16)57353-1. [DOI] [PubMed] [Google Scholar]
  14. Gumbiner B. M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996 Feb 9;84(3):345–357. doi: 10.1016/s0092-8674(00)81279-9. [DOI] [PubMed] [Google Scholar]
  15. Haning R. V., Jr, Austin C. W., Carlson I. H., Kuzma D. L., Shapiro S. S., Zweibel W. J. Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril. 1983 Jul;40(1):31–36. doi: 10.1016/s0015-0282(16)47173-6. [DOI] [PubMed] [Google Scholar]
  16. Haning R. V., Jr, Strawn E. Y., Nolten W. E. Pathophysiology of the ovarian hyperstimulation syndrome. Obstet Gynecol. 1985 Aug;66(2):220–224. [PubMed] [Google Scholar]
  17. Haselton F. R., Heimark R. L. Role of cadherins 5 and 13 in the aortic endothelial barrier. J Cell Physiol. 1997 Jun;171(3):243–251. doi: 10.1002/(SICI)1097-4652(199706)171:3<243::AID-JCP2>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  18. Hu R. M., Levin E. R., Pedram A., Frank H. J. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor. J Biol Chem. 1992 Aug 25;267(24):17384–17389. [PubMed] [Google Scholar]
  19. Keck P. J., Hauser S. D., Krivi G., Sanzo K., Warren T., Feder J., Connolly D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989 Dec 8;246(4935):1309–1312. doi: 10.1126/science.2479987. [DOI] [PubMed] [Google Scholar]
  20. Kendall R. L., Thomas K. A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10705–10709. doi: 10.1073/pnas.90.22.10705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kevil C. G., Payne D. K., Mire E., Alexander J. S. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem. 1998 Jun 12;273(24):15099–15103. doi: 10.1074/jbc.273.24.15099. [DOI] [PubMed] [Google Scholar]
  22. Kim K. J., Li B., Winer J., Armanini M., Gillett N., Phillips H. S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993 Apr 29;362(6423):841–844. doi: 10.1038/362841a0. [DOI] [PubMed] [Google Scholar]
  23. Kobayashi H., Okada Y., Asahina T., Gotoh J., Terao T. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome. J Mol Endocrinol. 1998 Jun;20(3):363–374. doi: 10.1677/jme.0.0200363. [DOI] [PubMed] [Google Scholar]
  24. Krasnow J. S., Berga S. L., Guzick D. S., Zeleznik A. J., Yeo K. T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril. 1996 Mar;65(3):552–555. [PubMed] [Google Scholar]
  25. Kwon O., Nelson W. J., Sibley R., Huie P., Scandling J. D., Dafoe D., Alfrey E., Myers B. D. Backleak, tight junctions, and cell- cell adhesion in postischemic injury to the renal allograft. J Clin Invest. 1998 May 15;101(10):2054–2064. doi: 10.1172/JCI772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lee A., Christenson L. K., Stouffer R. L., Burry K. A., Patton P. E. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril. 1997 Aug;68(2):305–311. doi: 10.1016/s0015-0282(97)81520-8. [DOI] [PubMed] [Google Scholar]
  27. Leung P., Ho Yuen B., Moon Y. S. Effect of prolactin in an experimental model of the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1983 Apr 1;145(7):847–849. doi: 10.1016/0002-9378(83)90690-7. [DOI] [PubMed] [Google Scholar]
  28. Levin E. R. Atrial natriuretic factor is detectable in human cerebrospinal fluid. J Clin Endocrinol Metab. 1988 May;66(5):1080–1083. doi: 10.1210/jcem-66-5-1080. [DOI] [PubMed] [Google Scholar]
  29. Ma T. Y., Hollander D., Bhalla D., Nguyen H., Krugliak P. IEC-18, a nontransformed small intestinal cell line for studying epithelial permeability. J Lab Clin Med. 1992 Aug;120(2):329–341. [PubMed] [Google Scholar]
  30. McClure N., Healy D. L., Rogers P. A., Sullivan J., Beaton L., Haning R. V., Jr, Connolly D. T., Robertson D. M. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet. 1994 Jul 23;344(8917):235–236. doi: 10.1016/s0140-6736(94)93001-5. [DOI] [PubMed] [Google Scholar]
  31. Millauer B., Shawver L. K., Plate K. H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature. 1994 Feb 10;367(6463):576–579. doi: 10.1038/367576a0. [DOI] [PubMed] [Google Scholar]
  32. Milton S. G., Knutson V. P. Comparison of the function of the tight junctions of endothelial cells and epithelial cells in regulating the movement of electrolytes and macromolecules across the cell monolayer. J Cell Physiol. 1990 Sep;144(3):498–504. doi: 10.1002/jcp.1041440318. [DOI] [PubMed] [Google Scholar]
  33. Murohara T., Horowitz J. R., Silver M., Tsurumi Y., Chen D., Sullivan A., Isner J. M. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998 Jan 6;97(1):99–107. doi: 10.1161/01.cir.97.1.99. [DOI] [PubMed] [Google Scholar]
  34. Navot D., Margalioth E. J., Laufer N., Birkenfeld A., Relou A., Rosler A., Schenker J. G. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril. 1987 Jul;48(1):57–61. doi: 10.1016/s0015-0282(16)59290-5. [DOI] [PubMed] [Google Scholar]
  35. Neulen J., Yan Z., Raczek S., Weindel K., Keck C., Weich H. A., Marmé D., Breckwoldt M. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 1995 Jun;80(6):1967–1971. doi: 10.1210/jcem.80.6.7775647. [DOI] [PubMed] [Google Scholar]
  36. Olson T. A., Mohanraj D., Carson L. F., Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res. 1994 Jan 1;54(1):276–280. [PubMed] [Google Scholar]
  37. Orvieto R., Voliovitch I., Fishman P., Ben-Rafael Z. Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. Hum Reprod. 1995 Jan;10(1):24–27. doi: 10.1093/humrep/10.1.24. [DOI] [PubMed] [Google Scholar]
  38. Pedram A., Razandi M., Hu R. M., Levin E. R. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem. 1997 Jul 4;272(27):17097–17103. doi: 10.1074/jbc.272.27.17097. [DOI] [PubMed] [Google Scholar]
  39. Polishuk W. Z., Schenker J. G. Ovarian overstimulation syndrome. Fertil Steril. 1969 May-Jun;20(3):443–450. doi: 10.1016/s0015-0282(16)37032-7. [DOI] [PubMed] [Google Scholar]
  40. Pride S. M., Ho Yuen B., Moon Y. S. Clinical, endocrinologic, and intraovarian prostaglandin F responses to H-1 receptor blockade in the ovarian hyperstimulation syndrome: studies in the rabbit model. Am J Obstet Gynecol. 1984 Mar 1;148(5):670–674. doi: 10.1016/0002-9378(84)90771-3. [DOI] [PubMed] [Google Scholar]
  41. Prins B. A., Hu R. M., Nazario B., Pedram A., Frank H. J., Weber M. A., Levin E. R. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem. 1994 Apr 22;269(16):11938–11944. [PubMed] [Google Scholar]
  42. Roberts W. G., Palade G. E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995 Jun;108(Pt 6):2369–2379. doi: 10.1242/jcs.108.6.2369. [DOI] [PubMed] [Google Scholar]
  43. Salzman A. L., Menconi M. J., Unno N., Ezzell R. M., Casey D. M., Gonzalez P. K., Fink M. P. Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol. 1995 Feb;268(2 Pt 1):G361–G373. doi: 10.1152/ajpgi.1995.268.2.G361. [DOI] [PubMed] [Google Scholar]
  44. Schenker J. G., Polishuk W. Z. The role of prostaglandins in ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol. 1976;6(2):47–52. doi: 10.1016/0028-2243(76)90001-0. [DOI] [PubMed] [Google Scholar]
  45. Schneeberger E. E., Lynch R. D. Structure, function, and regulation of cellular tight junctions. Am J Physiol. 1992 Jun;262(6 Pt 1):L647–L661. doi: 10.1152/ajplung.1992.262.6.L647. [DOI] [PubMed] [Google Scholar]
  46. Senger D. R., Galli S. J., Dvorak A. M., Perruzzi C. A., Harvey V. S., Dvorak H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983 Feb 25;219(4587):983–985. doi: 10.1126/science.6823562. [DOI] [PubMed] [Google Scholar]
  47. Terman B. I., Dougher-Vermazen M., Carrion M. E., Dimitrov D., Armellino D. C., Gospodarowicz D., Böhlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1579–1586. doi: 10.1016/0006-291x(92)90483-2. [DOI] [PubMed] [Google Scholar]
  48. Tsukamoto T., Nigam S. K. Tight junction proteins form large complexes and associate with the cytoskeleton in an ATP depletion model for reversible junction assembly. J Biol Chem. 1997 Jun 27;272(26):16133–16139. doi: 10.1074/jbc.272.26.16133. [DOI] [PubMed] [Google Scholar]
  49. Venema V. J., Marrero M. B., Venema R. C. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun. 1996 Sep 24;226(3):703–710. doi: 10.1006/bbrc.1996.1417. [DOI] [PubMed] [Google Scholar]
  50. Wu H. M., Huang Q., Yuan Y., Granger H. J. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol. 1996 Dec;271(6 Pt 2):H2735–H2739. doi: 10.1152/ajpheart.1996.271.6.H2735. [DOI] [PubMed] [Google Scholar]
  51. Yan Z., Weich H. A., Bernart W., Breckwoldt M., Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab. 1993 Dec;77(6):1723–1725. doi: 10.1210/jcem.77.6.8263163. [DOI] [PubMed] [Google Scholar]
  52. Zaidise I., Friedman M., Lindenbaum E. S., Askenazi R., Peretz B. A., Paldi E. Serotonin and the ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol. 1983 Apr;15(1):55–60. doi: 10.1016/0028-2243(83)90297-6. [DOI] [PubMed] [Google Scholar]
  53. Ziche M., Morbidelli L., Choudhuri R., Zhang H. T., Donnini S., Granger H. J., Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997 Jun 1;99(11):2625–2634. doi: 10.1172/JCI119451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. de Vries C., Escobedo J. A., Ueno H., Houck K., Ferrara N., Williams L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992 Feb 21;255(5047):989–991. doi: 10.1126/science.1312256. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES